Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 February 2020 | Story Xolisa Mnukwa | Photo Charl Devenish
Kovsie Eco vehicle parade
A highlight for first-year and senior students is the ACT eco-vehicle building and parade through the streets of Bloemfontein.

Sunny skies, cheerful faces, and an overall great atmosphere surfed the University of the Free State (UFS) Bloemfontein Campus on Saturday, 1 February 2020 for the final series of events in the Kovsie ACT 2020 line-up.

The eco-vehicle parade kick-started the activities for the day and saw various student teams displaying their personalised pit-stop ‘sculptures’ along the streets of Bloemfontein.  UFS residence teams Sonverlief (Houses Sonnedou, Veritas, Madelief); Soetmarmentum (Houses Soetdoring, Marjolein, Armentum); and Beykasium (Houses Beyers Naudé, Akasia, Imperium) came in first, second, and third respectively, obtaining the highest scores out of nine teams for their pit-stop sculpture constructions. 
 
Following the parade, there were a number of fun but competitive eco-vehicle races between the teams. This included the Drag Race, Obstacle Course Race, Formula E Race, Endurance Race, and the Slalom Course Race that took place on the Mokete Square. 

In the evening, students were serenaded by artists such as Early B and Spoegwolf. They danced to performances from the latest Amapiano music sensation, Kabza de Small, and legendary deep-house music duo, Black Motion, at the Rag Farm. 

Assistant Director of UFS Student Life and Director of the Kovsie ACT office, Karen Scheepers, earlier urged students to get more involved in student-life programmes such as Kovsie ACT, in order to equip themselves with a variety of skills and a fulfilling university experience.

A number of senior and first-year students who were part of the action on the UFS Bloemfontein Campus this past Saturday, can attest to Scheepers’ advice.
“I’ve been looking forward to starting university for the longest time, and I am glad that I ended up at the UFS. I don’t feel alone, I feel like I can actually do this,” said first-year Psychology student, Thulisa Shezi.

“University isn’t as bad as everyone thinks it is, it’s just a matter of staying motivated, doing your work, and surrounding yourself with the right people in the process.” – Fourth-year Business Management student, Earl van der Westhuisen.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept